Breaking News

More PPE for Covid-19 fight

Donations towards Covid-19 continue to pour in as Egypt, the Parliament of Zimbabwe and the business community, ...

Get breaking news alerts.
Don't miss a thing.
Subscribe

CORONA VIRUS WATCH

5 days ago | September 17, 2020

Pfizer says Covid-19 vaccine showed moderate side effects

Pfizer has said that Phase III clinical trial participants were experiencing mild-to-moderate side effects with its ...

COVID-19 and diabetes: a co-conspiracy?

Patients with diabetes have been in the spotlight since the early stages of the pandemic, as growing epidemiological ...

7 expert perspectives on what COVID-19 means for the planet

Experts agree that the legacy of the COVID-19 pandemic will be with us for years, even after the immediate threat has ...

6 days ago | September 16, 2020

COVID-19 has stalled 20 years of progress: Latest Goalkeepers report

Herald Reporter The Bill & Melinda Gates Foundation yesterday launched its fourth annual Goalkeepers Report, ...

African Leaders for Nutrition call on leaders to embed nutrition ...

Herald Reporter African Leaders for Nutrition have unveiled a position paper calling upon African Heads of State and ...

New antibody drug joins Oxford University trial of Coronavirus ...

Sarah Boseley The Oxford-based Recovery trial which proved that steroids saved the lives of some Covid patients will now ...

COVID-19 may become a seasonal virus

Rachael Rettner COVID-19 may eventually become a seasonal illness like the flu, but only when the population achieves ...

Study Finds Ibuprofen Likely Doesn’t Make COVID-19 Symptoms Worse

Kristen Fischer During the beginning of the COVID-19 outbreak in the United States, the World Health Organization (WHO) ...

1 week ago | September 15, 2020

5 factors that affect our COVID-19 vaccine response, according to ...

The Oxford vaccine trial at the centre of safety concerns highlights the idea that people’s immune systems respond to ...

Clinical trial for AstraZeneca Oxford COVID-19 vaccine candidate ...

After the clinical trial for AZD1222 was halted last week, the studies for AstraZeneca’s COVID-19 vaccine candidate will ...

Older teachers in Italy fear Covid-19 risks as schools return

Older Italian teachers and those with underlying illnesses fear the reopening of schools in Italy this week could pose ...

1 week ago | September 12, 2020

First Lady takes Covid-19 awareness to Budiriro

Tendai Rupapa Senior Reporter Covid-19 is far from over and citizens should guard against complacency and help stem the ...

2 weeks ago | September 11, 2020

The Time to Prepare for COVID-19 Vaccine Transport is Now

The International Air Transport Association (IATA) has urged governments to begin careful planning with industry ...

Covid-19: We have no idea where vaccine will come from, says expert

Sarah Boseley and agencies Nobody can know where the first safe and effective vaccine against Covid-19 will come from, ...

African Development Bank approves $27.33 million to ramp up the ...

Herald Reporter The African Development Bank’s Board of Directors on Wednesday approved US$27.33 million in grants to ...